DaVita
DVA
#1723
Rank
A$17.10 B
Marketcap
A$266.51
Share price
-3.01%
Change (1 day)
46.62%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$18.34

According to DaVita's latest financial reports the company's current EPS (TTM) is A$17.74. In 2025 the company made an earnings per share (EPS) of A$14.38 a decrease over its 2024 EPS that were of A$15.68.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$18.3427.52%
2025A$14.38-8.25%
2024A$15.6844.94%
2023A$10.8227.26%
2022A$8.50-35.56%
2021A$13.1944.1%
2020A$9.1519.7%
2019A$7.65540.48%
2018A$1.19-76.07%
2017A$4.99-19.31%
2016A$6.18242.52%
2015A$1.81-62.87%
2014A$4.8613.43%
2013A$4.298.45%
2012A$3.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$35.29 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$17.30-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$37.13 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$3.01-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA